A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05531682 · COMPLETED
Trial details
- NCT number
- NCT05531682
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-25
- Primary completion
- 2023-05-23
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.